Ashley Hall - 12 Nov 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role: Chief Development Officer
Signature: /s/ Vineet R. Jindal, Attorney-in-Fact
Issuer symbol: OKUR
Transactions as of: 12 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 15 Nov 2021, 18:49:17 UTC
Previous filing: 14 Oct 2021
Next filing: 13 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPHM	Common Stock	Award	$0	+30,000		$0.000000	30,000	12 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPHM	Stock Option (right to buy)	Award	$0	+180,000		$0.000000	180,000	12 Nov 2021	Common Stock	180,000	$8.85	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit award.
F2	1/4 of the shares subject to the stock option vest and become exercisable on October 11, 2022, and the remaining shares vest in equal monthly installments over the subsequent 36 months.